Strategic Partnerships Sedia Biosciences has recent collaboration with Thermo Fisher Scientific as a global authorized distributor under a co-exclusive agreement, signaling openness to enhanced distribution channels and potential cross-sell of genomics and diagnostic products.

Quality & Compliance With ISO 13485 certification achieved and WHO Pre-Qualification for Asanté HIV tests, there is a proven emphasis on stringent quality standards, presenting opportunities for high-trust supply agreements and contract manufacturing collaborations.

Pipeline & Services Recent launches including HIV oral fluid testing and SARS-CoV-2 whole genome sequencing services indicate a diversified product and service portfolio, suggesting cross-sell potential to customers seeking end-to-end diagnostic solutions.

Global Reach The company’s growth narrative through acquisitions like Floragenex and global distribution ties imply readiness to expand in international markets; potential for partnerships in genomics services, sequencing, and diagnostics on a broader scale.

SMB-scale Advantage With a lean team and revenue in the low millions, there may be opportunities for scalable, cost-effective solutions, managed services, and technology integrations that support rapid expansion without large enterprise commitments.